IMGN - ImmunoGen names Renee Lentini interim CFO as Susan Altschuller on medical leave
- ImmunoGen ( NASDAQ: IMGN ) on Wednesday said it had appointed Renee Lentini as interim CFO, replacing Susan Altschuller.
- The company said it had started a search for Altschuller's permanent replacement.
- "(Altschuller) is on leave under the Family and Medical Leave Act (FMLA) and will not continue employment with ImmunoGen at the conclusion of her leave," IMGN said in a statement .
- The company added that Altschuller's leave was unrelated to IMGN's financial or business performance.
- Lentini is currently serving as VP of finance and chief accounting officer.
- ImmunoGen ( IMGN ) stock earlier closed +7.5% at $4.89.
For further details see:
ImmunoGen names Renee Lentini interim CFO as Susan Altschuller on medical leave